Billev Pharma East ltd

Billev Pharma East provides end-to-end support for ATMP developers and manufacturers, from preclinical planning through clinical development, EU centralised approval, and post-authorisation lifecycle management. We help teams succeed by translating complex science into clear, regulator-ready language—shaping regulatory affairs strategy, scientific advice packages, key regulatory interactions, and high-impact medical writing for CTA/IMPD and MAA dossiers.By integrating regulatory, CMC, GMP and quality expertise, we de-risk development decisions, scale-up, inspections and lifecycle change to keep programmes moving efficiently toward patients.